Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)44.88
  • Today's Change-0.22 / -0.49%
  • Shares traded229.23k
  • 1 Year change+22.32%
  • Beta0.5053
Data delayed at least 15 minutes, as of Nov 05 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.

  • Revenue in EUR (TTM)1.43bn
  • Net income in EUR331.80m
  • Incorporated2006
  • Employees3.82k
  • Location
    Orion OyjOrionintie 1AESPOO 02200FinlandFIN
  • Phone+358 104261
  • Fax+358 104264435
  • Websitehttps://www.orion.fi/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bonesupport Holding AB69.83m7.77m1.86bn131.00241.8933.22214.5326.631.361.3612.299.921.160.61385.627,756,762.0012.85-9.0814.98-11.2892.4390.2511.12-11.653.50--0.0222--79.7643.65459.44--18.39--
Vimian Group AB352.10m255.79k1.99bn1.10k8,924.753.0057.945.640.0050.0058.3714.890.34012.856.753,733,535.000.0938--0.1025--46.88--0.2758--2.182.060.2734--17.92--245.95------
Bavarian Nordic A/S815.64m94.86m2.26bn1.38k23.641.6012.942.779.069.0678.44133.680.41571.505.104,410,899.004.831.216.241.4856.9153.7211.634.060.9311--0.01180.00124.1469.78524.66--35.76--
Camurus AB136.61m19.14m3.01bn228.00157.5311.96147.6122.053.793.7927.5149.940.61221.094.867,480,770.008.58-1.1310.10-1.4192.0190.0514.01-1.637.11--0.0071--79.52103.39676.63--16.29--
ALK-Abello A/S694.60m92.52m4.39bn2.81k52.297.2832.956.323.093.0922.9122.220.76731.276.111,834,278.0010.223.5012.564.3763.4260.6613.325.071.29479.500.09340.006.9410.6045.07--16.32--
Orion Oyj1.43bn331.80m6.36bn3.82k19.136.8516.254.452.362.3610.166.580.95931.536.94393,502.2022.2519.4728.2524.1659.8959.3823.1920.711.41143.690.217491.83-11.264.01-37.971.8911.821.55
Swedish Orphan Biovitrum AB (publ)2.18bn301.27m10.23bn1.81k33.333.1016.584.6910.0610.0672.98108.010.34431.375.7214,353,840.004.755.935.857.6078.6077.4213.8116.610.62254.350.3250.0017.7419.34-8.68-0.072953.61--
Data as of Nov 05 2024. Currency figures normalised to Orion Oyj's reporting currency: Euro EUR

Institutional shareholders

19.52%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 02 Oct 20243.74m3.45%
Keskin�inen Ty�el�kevakuutusyhti� Varmaas of 28 Feb 20233.18m2.94%
Norges Bank Investment Managementas of 30 Jun 20242.66m2.46%
BlackRock Fund Advisorsas of 03 Oct 20242.64m2.44%
Keskin�inen El�kevakuutusyhti� Ilmarinenas of 21 Jun 20231.93m1.78%
Dimensional Fund Advisors LPas of 03 Oct 20241.63m1.51%
Keskin�inen Ty�el�kevakuutusyhti� Eloas of 28 Feb 20231.59m1.47%
Sp-Fund Management Co. Ltd.as of 30 Sep 20241.27m1.18%
Amundi Asset Management SA (Investment Management)as of 02 Oct 20241.26m1.17%
The Social Insurance Institution of Finland (Invt Port)as of 28 Feb 20231.22m1.13%
More ▼
Data from 04 Mar 2024 - 30 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.